Sign in
4

Changes in Ownership

Eloxx Pharmaceuticals, Inc. Filed Acc 0001415889-20-001306

Options or other derivatives

  • 10% owner acquired 40,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Pontifax Management 4 G.P. (2015) Ltd. · 10% owner

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2020-05-20 Grant or award : show line 1 in the form Stock Option (Right to Buy) +20,000 20,000 I
2020-05-20 Grant or award : show line 2 in the form Stock Option (Right to Buy) +20,000 20,000 I
Loading xslF345X03/form4-05222020_040544.xml…